Norges Bank’s Pacira BioSciences PCRX Stock Holding History

Norges Bank’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-127,655	Closed	-$2.41M	–	1823
2024 Q4	$2.41M	Sell	127,655 -141,649	-53%	-$2.49M	﹤0.01%	1668
2024 Q3	$4.05M	Buy	269,304 +59,247	+28%	+$1.01M	﹤0.01%	1564
2024 Q2	$6.01M	Sell	210,057 -37,948	-15%	-$1.08M	﹤0.01%	1517
2024 Q1	$7.25M	Sell	248,005 -34,798	-12%	-$1.07M	﹤0.01%	1538
2023 Q4	$9.54M	Sell	282,803 -16,745	-6%	-$490K	﹤0.01%	1501
2023 Q3	$9.19M	Sell	299,548 -14,059	-4%	-$507K	﹤0.01%	1511
2023 Q2	$12.6M	Sell	313,607 -89,857	-22%	-$3.71M	﹤0.01%	1440
2023 Q1	$16.5M	Buy	403,464 +631	+0.2%	+$25.1K	﹤0.01%	1365
2022 Q4	$15.6M	Hold	402,833	–	–	﹤0.01%	1388
2022 Q3	$21.4M	Sell	402,833 -269	-0.1%	-$15K	0.01%	1172
2022 Q2	$23.5M	Sell	403,102 -13,259	-3%	-$869K	0.01%	1162
2022 Q1	$31.8M	Buy	416,361 +24,853	+6%	+$1.66M	0.01%	1139
2021 Q4	$23.6M	Buy	391,508 +131,982	+51%	+$7.28M	﹤0.01%	1389
2021 Q3	$14.5M	Sell	259,526 -41,078	-14%	-$2.37M	﹤0.01%	1640
2021 Q2	$18.2M	Sell	300,604 -73,296	-20%	-$4.64M	﹤0.01%	1582
2021 Q1	$26.2M	Sell	373,900 -97,412	-21%	-$6.96M	0.01%	1368
2020 Q4	$28.2M	Hold	471,312	–	–	0.01%	1362
2020 Q3	$28.3M	Sell	471,312 -71,355	-13%	-$4.15M	0.01%	1197
2020 Q2	$28.5M	Buy	542,667 +1,454	+0.3%	+$60.8K	0.01%	1209
2020 Q1	$18.1M	Hold	541,213	–	–	0.01%	1311
2019 Q4	$24.5M	Sell	541,213 -24,838	-4%	-$1.05M	0.01%	1416
2019 Q3	$21.6M	Buy	566,051 +16,500	+3%	+$659K	0.01%	1441
2019 Q2	$23.9M	Buy	549,551 +109,414	+25%	+$4.65M	0.01%	1392
2019 Q1	$16.8M	Buy	440,137 +23,929	+6%	+$934K	0.01%	1602
2018 Q4	$17.9M	Buy	416,208 +42,427	+11%	+$1.98M	0.01%	1468
2018 Q3	$18.4M	Buy	373,781 +132,593	+55%	+$5.73M	0.01%	1579
2018 Q2	$7.73M	Sell	241,188 -168,378	-41%	-$5.81M	﹤0.01%	1874
2018 Q1	$12.8M	Buy	409,566 +49,498	+14%	+$1.76M	﹤0.01%	1661
2017 Q4	$16.4M	Hold	360,068	–	–	0.01%	1555
2017 Q3	$13.5M	Hold	360,068	–	–	0.01%	1638
2017 Q2	$17.2M	Buy	360,068 +27,849	+8%	+$1.29M	0.01%	1503
2017 Q1	$15.1M	Sell	332,219 -78,248	-19%	-$3.38M	0.01%	1559
2016 Q4	$13.3M	Hold	410,467	–	–	0.01%	1563
2016 Q3	$13.4M	Buy	410,467 +95,682	+30%	+$3.75M	0.01%	1486
2016 Q2	$10.6M	Buy	314,785 +104,298	+50%	+$5.13M	0.01%	1576
2016 Q1	$11.2M	Buy	210,487 +13,428	+7%	+$785K	0.01%	1502
2015 Q4	$15.1M	Buy	197,059 +62,709	+47%	+$3.55M	0.01%	1335
2015 Q3	$5.52M	Sell	134,350 -17,759	-12%	-$1.09M	﹤0.01%	1816
2015 Q2	$10.8M	Hold	152,109	–	–	0.01%	1581
2015 Q1	$13.5M	Sell	152,109 -17,427	-10%	-$1.77M	0.01%	1471
2014 Q4	$15M	Buy	169,536 +48,180	+40%	+$4.56M	0.01%	1399
2014 Q3	$11.8M	Sell	121,356 -121,356	-50%	-$11.8M	0.01%	1499
2014 Q2	$22.3M	Buy	+242,712	New	+$18.5M	0.01%	1576

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Norges Bank's PCRX Position: Q1 2025 in Review

Norges Bank sold out of Pacira BioSciences (PCRX) in Q1 2025, closing a stake of 127,655 shares — an estimated $2.41M sold.

Norges Bank first reported a position in PCRX in Q2 2014 and held it in 43 quarters. The position peaked at $31.8M in Q1 2022. 235 funds tracked by Wall St. Rank hold PCRX as of Q1 2025.

Norges Bank reported no remaining Pacira BioSciences position as of Q1 2025 after selling out during the quarter.
Norges Bank sold 127,655 Pacira BioSciences shares in Q1 2025, an estimated $2.41M.
Norges Bank first reported a position in Pacira BioSciences in Q2 2014 and held it in 43 quarters.
Norges Bank's Pacira BioSciences position peaked at $31.8M in Q1 2022.
235 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.